Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of Thrombosis and Thrombolysis|October 4, 2016
Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort studySimon Mantha, Eva Laube, Yimei Miao, et al.
Research and Practice in Thrombosis and Haemostasis|July 12, 2019
Rivaroxaban treatment of cancer-associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experienceGerald A Soff, Jodi Mones, Cy Wilkins, et al.
Research Square|May 22, 2023
Application of Machine Learning to the Prediction of Cancer-Associated Venous ThromboembolismSimon Mantha, Subrata Chatterjee, Rohan Singh, et al.
Blood Advances|March 24, 2024
Machine learning natural language processing for identifying venous thromboembolism: systematic review and meta-analysisBarbara D Lam, Pavlina Chrysafi, Thita Chiasakul, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2019
Romiplostim Treatment of Chemotherapy-Induced ThrombocytopeniaGerald A Soff, Yimei Miao, Gemma Bendheim, et al.
British Journal of Haematology|December 18, 2012
Prediction and prevention of thromboembolic events with enoxaparin in cancer patients with elevated tissue factor-bearing microparticles: a randomized-controlled phase II trial (the Microtec study)Jeffrey I Zwicker, Howard A Liebman, Kenneth A Bauer, et al.
AJR. American Journal of Roentgenology|March 30, 2022
Antithrombotic Therapy After Venous Interventions: AJR Expert Panel Narrative ReviewSirish Kishore, Minhaj S Khaja, Bartley Thornburg, et al.
Science Translational Medicine|June 17, 2026
Plasma proteomics improves thrombosis prediction in patients with cancer and identifies targetable IL-17-driven endothelial activationDimitra Karagkouni, Marisa A Brake, Rushad Patell, et al.
Blood Advances|December 26, 2023
High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancerAaron J Stonestrom, Kamal N Menghrajani, Sean M Devlin, et al.
Blood|December 3, 2020
Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumorsAndrew Dunbar, Kelly L Bolton, Sean M Devlin, et al.
Pageof 4